The metadrenalines, normetadrenaline and metad renaline, are produced by O-methylation of norad renaline and adrenaline, a reaction catalysed by catechol-O-methyltransferase (COMT) [1] . Because COMT is localized mainly in non-neuronal tissues, normetadrenaline is produced by extraneuronal metabolism of the noradrenaline released by nerves that escapes reuptake [2] . In contrast, the deaminated metabolites of noradrenaline, dihydroxyphenylglycol (DHPG) and methoxyhydroxyphenylgly-
1. The clinical utility of plasma metadrenalines for examination of sympatho-adrenal function and cate cholamine metabolism was assessed from plasma measurements of these metabolites in a number of clinical conditions (hypertension, cardiac failure, bila teral adrenalectomy and X-chromosomal deletions of the gene for monoamine oxidase), and before and during activation of sympathetic outflow or infusions of noradrenaline and adrenaline. 2. Plasma concentrations of normetadrenaline were less than 25% of those of noradrenaline, concenti, rations of metadrenaline and adrenaline were similar and those of sulphate-conjugated metadrenalines were 20-to 30-fold higher than free metadrenalines. Hypertensive patients had elevated plasma concent rations of adrenaline, noradrenaline and conjugated but not free metadrenalines. Cardiac failure patients had 2-to 4-fold increases in plasma noradrenaline and free and conjugated normetadrenaline. Adrenalec tomy resulted in undetectable plasma concentrations of adrenaline, 91-97% decreases in free and conju gated metadrenaline and a 40% decrease in normet adrenaline relative to noradrenaline. Patients with Xchromosomal deletions of the gene for monoamine oxidase had 6-and 16-fold increases in plasma free and conjugated normetadrenaline and 2-and 4-fold increases in free and conjugated metadrenaline. 3. Infusion of catecholamines increased plasma con centrations of free metadrenalines by less than 6% of increases in precursor amines, indicating that most plasma normetadrenaline (84%) and metadrenaline (90%) is derived from metabolism of catecholamines before their entry into the circulation. Considerable O-methylation of catecholamines within the adrenals explains why sympatho-adrenal activation resulted in smaller proportional increases in plasma metadrena lines than catecholamines. 4 . Plasma metadrenalines provide supplementary information about sympatho-adrenal activity to that provided by catecholamines, but are more useful for examination of the extraneuronal inactivation of catecholamines, particularly detection of neurochemi cal phenotypes in genetic disorders of catecholamine metabolism. Significant formation of metadrenalines within chromaffin tissue explains why measurements of plasma metadrenalines provide an extraordinarily sensitive method for diagnosis of phaeochromocytoma.
col, are derived largely from the intraneuronal meta bolism of the noradrenaline that leaks from storage vesicles [3, 4] . The above metabolic differences suggest that normetadrenaline, in conjunction with other metabolites, may offer a useful marker of noradrenaline release as distinct from noradrenaline turnover [5] . In rats, measurements of plasma metadrenalines have indeed been shown to offer a useful method for examination of extraneuronal b uptake and metabolism of catecholamines [6] [7] [8] . Studies of plasma metadrenalines in humans, how ever, are limited [9] [10] [11] .
The clinical utility of plasma metadrenalines for examination of sympatho-adrenal function and cate cholamine metabolism was therefore explored by studies that answered the following questions. Do the metadrenalines provide useful markers of sympatho-adrenal activity at rest and during sym pathetic activation associated with mental stress, lower body negative pressure and cycling exercise? What proportions of plasma normetadrenaline and metadrenaline derive from metabolism of circulating catecholamines? Can plasma metadrenalines provide additional information to plasma catecholamines in clinical conditions affecting sympatho-adrenal func tion such as adrenalectomy, heart failure, hyperten sion, angina pectoris, renal artery stenosis and Xchromosomal delations or mutations affecting monoamine oxidase (MAO)?
METHODS

Subjects
The study included 81 normal control subjects, 50 patients with essential hypertension, 24 patients with angina, 35 patients with heart failure, 11 patients with renal artery stenosis, 11 patients with bilateral adrenalectomies, five Norrie disease patients with Xchromosomal deletions affecting MAO and one patient who underwent inferior vena cava regional blood sampling to localize the site of a suspected phaeochromocytoma. Subjects were studied as part of ongoing protocols at three different institutions: the National Institutes of Health, the University of Göteborg and St Radboud University Hospital. All procedures were approved by the appropriate ethics committee and all patients (and parents of Norrie disease patients) gave informed consent before blood samples were taken or studies began. Blood samples were taken with subjects in the supine position. The physical characteristics (age and sex) and sites of blood sampling for the subjects of the various groups are summarized in Table 1 .
Hypertension. A diagnosis of essential hyperten
sion was made if the mean of blood pressure values determined on three separate outpatient visits was higher than 140 mmHg (systolic) or 90 mmHg (dias tolic). At each visit, blood pressure was measured as the mean of two readings after at least 5 min of supine rest. Secondary hypertension was excluded Inferior vena cava blood sampling. One patient underwent inferior vena cava sampling of blood to localize a suspected phaeochromocytoma. The patient was subsequently determined not to harbour a phaeochromocytoma, but samples from the infer-ior vena cava and renal and adrenal veins were analysed to assess the possible contribution of the adrenal medullae to circulating plasma concent rations of metadrenalines.
Activation of sympathetic outflow
i Lower body negative pressure. In five control subjects and five hypertensive patients, blood samples were taken simultaneously from a brachial artery and from a deep antecubital vein, before and 15 min after the start of lower body negative pres sure (at -40 mmHg).
Mental challenge. In 11 patients with microvascular angina, arterial blood samples were taken in the supine position before and 5 min after subjects started playing a video game, previously demon strated to elicit increases in plasma catecholamines [17] .
Exercise. Twenty-eight patients, including 18
patients with cardiac failure and ten control sub jects, performed cycling exercise in the supine position. Arterial blood samples were taken before and during the last minute of cycling exercise, between 10 and 24 min after the start of exercise.
Infusions of 3H-labelled catecholamines
All patients who underwent the manipulations described above received infusions of [3H]noradrenaline (L-2,5,6-[3H]noradrenaline, 40-60Ci/mmol; New England Nuclear, Boston, MA, U.S.A.) either delivered alone or in combination with [ 3H]adrenaline (L-iV-methyl-[3H] adrenaline, > 65-75 Ci/mmol; New England Nuclear). The radio tracers were infused into a forearm vein at 1.0-1.5/iCi/min. Blood samples were taken at intervals between 15 and 145 min after the start of infusions. The preparation, storage and handling of the radio tracers has been described in detail elsewhere [18] .
Analytical methods
Metadrenaline assays. The metadrenalines (normet adrenaline and metadrenaline) were extracted from 2 ml samples of plasma using solid-phase ionexchange columns and were quantified by liquid chromatography with electrochemical detection [11] . Samples from subjects who received intrave nous infusions of 3H-labelled catecholamines under went timed collections of the eluant leaving the electrochemical cell, enabling determination of plasma concentrations of 3H-labelled normetadrena line and metadrenaline by liquid-scintillation spec troscopy. Plasma concentrations of sulphateconjugated normetadrenaline and metadrenaline were determined from 0.25 ml samples of plasma that were subjected to enzymic deconjugation by incubation with 0.2 unit of sulphatase (Sigma; St Louis, MO, U.S.A.) for 30min at 37°C. Inter-assay coefficients of variation were 12.2% for normetadren aline and 11.2% for metadrenaline. Intra-assay co efficients of variation were 4.2% for normetadren aline and 3.3% for metadrenaline.
Catechol assays. The catechols (noradrenaline, adrenaline and DHPG) were determined by liquid chromatography with electrochemical detection after extraction by alumina adsorption [19] . Inter-assay coefficients of variation were 6.5% for noradrenaline, 11.4% for adrenaline and 8.4% for DHPG. Intra assay coefficients of variation were 1.9% for norad renaline, 3.0% for adrenaline and 4.8% for DHPG.
Data analysis
Calculations. The proportion (P ) of endogenous free normetadrenaline in plasma formed from meta bolism of circulating noradrenaline, or of free metadrenaline formed from circulating adrenaline (i.e. that derived from the catecholamine after its release or entry into the plasma compartment) was estimated according to a previously established method [6] , using the equation:
where C is the plasma concentration of endogenous catecholamine precursor (pmol/ml), M is the plasma concentration of endogenous metabolite (pmol/ml), [3H]C is the steady-state plasma concentration of intravenously infused 3H-labelled catecholamine (d.p.m./ml) and [3H]M is the respective plasma concentration of the 3H-labelled metabolite (d.p.m./ ml) during infusion of 3H-labelled catecholamine precursor.
Statistical methods. Results are expressed as means+ SEM. Plasma concentrations of normetad renaline and metadrenaline were not normally dis tributed. Therefore, for the most part, levels of statistical significance were determined using nonparametric methods: Wilcoxon's signed-rank sum test was used for comparisons of paired data, the Mann-Whitney U -test was used for comparisons of non-paired data, and the significance of relation ships was assessed using Spearman's rank correla tion coefficient. Where parametric methods were used (i.e. analysis of variance to assess gender-group interactions), levels of significance were determined after logarithmic transformation of the data. Unless stated, statistical significance was defined as P<0.05.
RESULTS
Free and conjugated metadrenalines
Forearm venous plasma concentrations of nor metadrenaline in control subjects were low, averag ing less than 25% of those of noradrenaline and ranging between 0.09 and 0.62 pmol/ml ( Table 2 ). In contrast, venous plasma concentrations of met adrenaline were similar to those of adrenaline, rang ing between 0.03 and 0.36 pmol/ml. Both normet adrenaline and metadrenaline were extensively sulphate-conjugated, so that concentrations of the conjugates were 20-to 30-fold higher than concent rations of free compounds.
(r = 0.30, P c 0.002), but no age-related relationships were apparent for adrenaline or metadrenaline. The observed gender differences in plasma catechola mines and metadrenalines were unrelated to any gender difference in age distribution (39 ± 1 years in males compared with 41 ± 2 years in females).
Forearm arteriovenous differences
In the ten subjects from whom simultaneous arterial and forearm venous blood samples were obtained, arteriovenous differences in plasma con centrations of metadrenalines showed a similar, albeit less dramatic, pattern to the parent amines. Venous concentrations of metadrenaline were 24 + 9% lower ( P < 0.05) than arterial concent rations, whereas venous concentrations of normet adrenaline were slightly (18 + 14%), but not signifi cantly, higher than »arterial concentrations. Forearm venous concentrations of adrenaline were 75 + 2% lower (PcO.Ol) than arterial concentrations, whereas venous noradrenaline concentrations were 23 + 7% higher ( P c 0.05) than arterial concentrations.
Influence of gender and age
Gender. Consistent sex differences in forearm venous plasma concentrations of metadrenaline, metadrenaline sulphate and adrenaline were observed for both hypertensive and control subjects. Plasma adrenaline was higher ( P < 0.001) in males than in females (0.17 + 0.02 compared with 0.11+0.01 pmol/ml), a difference that was significant for both hypertensive and normotensive groups considered alone. This difference was also reflected in higher ( P c 0.02) concentrations in males than females of both metadrenaline (0.16 + 0.01 compared with 0.13 + 0.01 pmol/ml) and metadrenaline sul phate (4.00 + 0.23 compared with 3.18 + 0.17 pmol/ ml). Except for higher ( P c 0.05) concentrations of normetadrenaline in female compared with male control subjects (0.32 + 0.02 and 0.26 ±0.02 pmol/ml, respectively), there were no other gender differences in noradrenaline and its O-methylated metabolites.
Age. There were weak positive relationships between age and plasma concentrations of noradre naline (r=0.29, P < 0.002), normetadrenaline (r = 0.21, P c 0.05) and normetadrenaline sulphate
Comparisons among subject groups
Due to the differences between arterial and fore arm venous plasma concentrations of metadrena lines and catecholamines, comparisons among sub ject groups were made according to the site of blood sampling.
Hypertension. In patients with essential hyperten sion, venous plasma concentrations of noradrenaline and adrenaline and of conjugated normetadrenaline and metadrenaline were 15-25% higher ( P c 0.02) than in control subjects, whereas concentrations of unconjugated normetadrenaline and metadrenaline were not significantly different ( Table 2) . Increased plasma concentrations of metadrenaline sulphate and adrenaline in hypertensive patients were inde pendent of gender. In contrast, there was a signifi cant (PcO.Ol) group-gender interaction for plasma normetadrenaline, such that plasma concentrations of this metabolite were higher in hypertensive than normotensive males (0.35 + 0.03 compared with 0.26 ±0.02 pmol/ml), but not in females (0.28 + 0.03 compared with 0.32 ±0.02 pmol/ml). There was no associated group-gender interaction for plasma noradrenaline.
Bilateral adrenalectomy. In adrenalectomized sub jects, forearm venous plasma concentrations of adre naline were below the detection limits of the assay (<0.015 pmol/ml). Plasma concentrations of free and conjugated metadrenaline were detectable, but were decreased (P < 0.001) by more than 91% com pared with control subjects ( Table 2) . Adrenalec tomy was associated with decreased plasma concen trations of normetadrenaline and increased concen trations of noradrenaline, but these differences did not reach significance. Considered together, how ever, the ratio of plasma normetadrenaline to nor adrenaline concentrations was 43% lower (PcO.Ol) in adrenalectomized subjects than in control sub jects (0.144 + 0.013 compared with 0.254±0.015).
a Clinical significance of plasma metadrenalines 537 Table 3 . A rte ria l plasma concentrations of catecholamines and free and total metadrenalines in control subjects and patients w ith angina pectoris, renal arte ry stenosis and cardiac failure* Values are expressed as means ±SEM. ^Significantly higher concentrations (P<0.05) compared with control subjects, as determined by Mann-Whitney U-test. tSamples from these groups include some taken from venous sampling sites (see Table I ), but observed differences remained significant when comparisons were made with the control subjects from whom venous samples were taken (see Table 2 ). disease showed considerable increases ( P c 0.001) above normal in forearm venous plasma concent rations of free (6.1-fold increase) and conjugated (15.7-fold increase) normetadrenaline ( Table 2) . Plasma concentrations of free and conjugated metadrenaline were also increased (PcO.Ol), although the extent of these increases was not as large (about a third) as those observed for free and conjugated normetadrenaline. Plasma concent rations of conjugated metadrenaline and normet adrenaline were increased 50 and 160% above normal than the respective concentrations of free metadrenalines. Plasma noradrenaline was increased by 2-fold ( P c 0.05) in Norrie disease patients, where as plasma adrenaline was unaffected. Plasma concentrations of DHPG were below the limits of detection ( P c 0.02) in all five patients with Norrie disease.
Angina pectoris. Patients with angina pectoris had higher ( P c 0.05) arterial plasma concentrations of conjugated normetadrenaline than control subjects, but apart from this there were no other differences for this subject group (Table 3) .
Renal artery stenosis. Plasma concentrations of noradrenaline and free and conjugated normet adrenaline were 2.1-to 2.7-fold higher (PcO.Ol) in patients with renal artery stenosis than in control subjects, whereas concentrations of adrenaline and free and conjugated metadrenaline were not differ ent (Table 3 ).
Cardiac failure. Cardiac failure was associated with 2.3-to 3.6-fold higher ( P c 0.001) plasma con centrations of noradrenaline and free and conju gated normetadrenaline than in control subjects ( Table 3 ). Plasma concentrations of adrenaline and metadrenaline sulphate were also increased (P cO .01) in patients with heart failure, but concent rations of free metadrenaline were not affected.
Relationships among plasma catecholamines and metabol ites
There were significant ( P c 0.001) positive rela-renaline and normetadrenaline or DHPG, as well as between plasma concentrations of adrenaline and metadrenaline (Fig. 1) . Although all linear regres sion lines intersected the y-axis (metabolite axis) above the origin, this was most apparent for the regression line describing the relationship between plasma noradrenaline and DHPG.
Positive linear relationships ( P c 0.001) were also observed between plasma concentrations of free and sulphate-conjugated normetadrenaline or metadren aline (data not shown). (Fig. 3a) .
Infusion of
Comparison of the ratio of steady-state arterial plasma concentrations of free [3H]normetadrenaline to [3H]noradrenaline with the ratio of arterial tionships between plasma concentrations of norad-plasma concentrations of endogenous normetadre- naline to noradrenaline, indicated that 15.8 + 1.4% of the endogenous free normetadrenaline in plasma was derived from metabolism of noradrenaline after it entered the circulation (Fig. 3b) . Surprisingly, ratios of 3H-labelled and endogenous metadrenaline to adrenaline indicated that only 10.1 ±1.9% of the endogenous free metadrenaline in plasma was der ived from adrenaline after it was released into the circulation, a proportion that was actually less (PcO.Ol) than that for the endogenous normetadren aline produced from circulating noradrenaline.
Inferior vena cava blood sampling
In the patient who underwent inferior vena cava regional blood sampling, the plasma concentration of adrenaline in the right adrenal vein was 45-fold higher than in the downstream vena cava sampling site ( Table 4 ). The plasma concentration of met adrenaline was 12-fold higher in the adrenal vein % than in the vena cava. The plasma normetadrenaline concentration was also higher in the adrenal vein than at other sampling sites. Plasma concentrations of adrenaline and metadrenaline were higher in the left renal vein, which drains both the left kidney and adrenal gland, than in the right renal vein, which drains only the right kidney.
Activation of sympathetic outflow
Application of -40 mmHg of lower body negative pressure, mental challenge and supine cycling exer cise all increased (PcO.Ol) plasma normetadrenaline and plasma noradrenaline. Percentage increases in plasma normetadrenaline were considerably and consistently lower (PcO.Ol) than increases in plasma noradrenaline in response to all stimuli (Fig.  4a) .
Lower body negative pressure, mental challenge and cycling exercise also increased ( P c 0.001) plasma adrenaline, but only lower body negative pressure increased plasma metadrenaline. Again, metadrenaline responses were considerably and con sistently smaller than adrenaline responses to all stimuli (Fig. 4b ).
DISCUSSION
«
The results show that measurement of plasma metadrenalines provides information about sympatho-adrenal activity that supplements that provided by the parent amines. More importantly, these metabolites provide information about cate cholamine metabolism in extraneuronal tissues, including the adrenal medullae, that is not available from measurements of the parent amines alone.
Other reports about the clinical utility of plasma metadrenalines for assessment of sympatho-adrenal activity are largely limited to those of DeQuattro and colleagues [9, 10, [20] [21] [22] [23] , who used a radioenzymic assay to measure plasma concentrations of normetadrenaline in hypertension and during vari ous manipulations of sympathetic outflow. The radioenzymic assay depends on N-terminal méthyla tion of normetadrenaline, so that metadrenaline cannot be measured. The present use of liquid chromatography with electrochemical detection allows measurements of both metadrenaline and normetadrenaline.
The much lower plasma concentrations of free normetadrenaline than of noradrenaline, but higher concentrations of normetadrenaline sulphate, the age-dependence of plasma noradrenaline and nor metadrenaline, higher plasma concentrations in hypertensive than in normotensive subjects and increases in concentrations during sympathetic acti vation agree well with previous findings [9, 10, [20] [21] [22] [23] [24] [25] . The parallel increases in plasma normetadrena line and noradrenaline in heart failure also support the view that plasma normetadrenaline reflects sym pathetic outflow. Thus, measurement of normetadren aline as an index of sympathetic outflow provides supplementary information that may strengthen the conclusions derived from measurements of noradren aline. However, the proportionally smaller changes in plasma concentrations of free normetadrenaline than of noradrenaline during mental challenge, lower body negative pressure and exercise, indicate that normetadrenaline is a less sensitive index of acute changes in sympathetic outflow than noradrenaline.
Similarly, the much smaller increases in plasma metadrenaline than adrenaline during sympatho adrenal activation also indicate that changes in plasma metadrenaline are a less sensitive index of acute changes in adrenal medullary secretion of adrenaline than the parent amine itself. Neverthe less, the findings of higher plasma concentrations of adrenaline in hypertensive than in normotensive subjects and in males than in females, while consis tent with other studies [26, 27] , are further sup ported and strengthened by similar differences in plasma concentrations of free or sulphateconjugated metadrenaline. An explanation for the insensitivity of plasma metadrenalines to acute changes in sympatho adrenal activation is provided by the observations about production of free metadrenalines from infused catecholamines. Similar plasma concent rations of endogenous metadrenaline to adrenaline, despite increases in plasma metadrenaline that were only 6% of those of infused adrenaline, indicated that most (90%) of the free metadrenaline in plasma is derived from metabolism of adrenaline before its release into the circulation, and is therefore unlikely to be responsive to acute changes in adrenaline release. The relative independence of metadrenaline production on adrenaline release is further reflected by the regression line for the relationship between plasma metadrenaline and adrenaline that inter sected the y-axis well above the origin. Comparison of the ^-intercept value of metadrenaline (0.13 pmol/ ml) with mean plasma concentrations of metadrena line in control subjects (0.14 pmol/ml) indicates that 90% of metadrenaline in plasma is independent of adrenaline release into the circulation.
Other findings in adrenalectomized rats showing normal plasma concentrations of metadrenaline despite undetectable adrenaline concentrations, sug gested that much of the metadrenaline in plasma might be derived from adrenaline synthesized at extra-adrenal sites [6] . The results in patients with bilateral adrenalectomy indicate that, in humans, at least 91% of the metadrenaline in plasma is derived from adrenaline synthesized in the adrenals. This could reflect metabolism of adrenaline within the adrenals or local metabolism of adrenaline taken up and released by extra-adrenal tissues after synthesis and initial release by the adrenals. The former source is suggested by the high metadrenaline con centrations in plasma draining the adrenal veins.
Higher plasma concentrations of normetadrena line in the adrenal vein than the vena cava, the lower ratio of normetadrenaline to noradrenaline concentrations in adrenalectomized patients than control subjects, and other findings of higher left renal than right renal venous plasma normetadrena line concentrations [9] , indicate that some circulat ing normetadrenaline is also derived from metabo lism of noradrenaline within the adrenals. A contribution of the adrenals to plasma normetadren aline is consistent with the regression line for the relationship between plasma noradrenaline and nor metadrenaline that intersected the y-axis above the origin. Comparison of the ^-intercept value of nor metadrenaline (0.11 pmol/ml) with mean plasma concentrations of normetadrenaline in control sub jects (0.29 pmol/ml), suggests a 38% contribution of the adrenals to plasma normetadrenaline. Similarly, comparison of the ratio of plasma normetadrenaline to noradrenaline in adrenalectomized (0.144) and control (0.254) subjects, indicates a 45% [(0.254 -0.144)/0.244] contribution of the adrenals to plasma concentrations of normetadrenaline. For mation of metadrenalines within the adrenals is further supported by immunohistochemical findings of COMT-positive cells in cortical layers of the adrenal gland [28, 29] .
Although the metadrenalines provide little new information about sympatho-adrenal activity to that provided by the parent amines, the source of these metabolites makes them particularly useful for examination of catecholamine metabolism in extra neuronal tissues, including the adrenal medullae and tumours of chromaffin-cell origin. Comparison of plasma concentrations of catecholamines and metadrenalines in a large group of phaeochromocy toma patients showed that plasma metadrenalines were increased more consistently, and considerably more above normal, than plasma catecholamines (J. Lenders et al., unpublished work). In particular, patients with Von Hippel-Lindau's disease, a geneti cally inherited disorder associated with susceptibility to develop phaeochromocytomas, show increased plasma metadrenalines well before other tests (e.g. plasma catecholamines, clonidine suppression, gluca gon stimulation) provide a positive diagnosis of the tumour. The extraordinarily high sensitivity of plasma metadrenalines for diagnosis of phaeochro mocytoma can be explained by the present findings of active O-methylation of catecholamines within the adrenal gland, and presumably therefore in tumours derived from chromaffin tissue. High con centrations of normetadrenaline in the venous N drainage of phaeochromocytomas [22] support this possibility. Even when quiescent or not releasing catecholamines, the tumours appear to be actively metabolizing catecholamines to the O-methylated derivatives.
Although as much as 40% of plasma normetadren aline is derived from metabolism of noradrenaline within the adrenal medullae, most (60%) is derived from extraneuronal metabolism of neuronally released noradrenaline before or after entry of the transmitter into the circulation. The increases in plasma concentrations of free normetadrenaline from infused noradrenaline indicate that 16% of the free normetadrenaline in plasma is derived from metabolism of circulating noradrenaline. Thus, 73% [(60-16)/60] of the normetadrenaline that is der ived from neuronally released noradrenaline is formed by extraneuronal metabolism before entry of the transmitter into the circulation, leaving 27% formed from metabolism after entry of noradrena line into the circulation. This compares with the neuronal metabolite of noradrenaline, DHPG, of which less than 2% is derived from circulating noradrenaline [7] .
The extraneuronal source of normetadrenaline, as distinct from the neuronal source of DHPG, is reflected by the relationships of normetadrenaline and D H PG with noradrenaline and production of both metabolites from infused [3H]noradrenaline. The regression line for the relationship between plasma noradrenaline and DHPG intersected the yaxis well above the origin, consistent with formation of most DHPG from metabolism of noradrenaline leaking from vesicles and not released by nerves [3, 4, 30] . In contrast, the relationship between nor metadrenaline and noradrenaline intersected the yaxis closer to the origin, consistent with formation of most (60%) normetadrenaline from neuronally released noradrenaline.
During infusion of [3H]noradrenaline, the pro gressive increase in plasma [3H]DHPG with time reflects continuous loading of neuronal vesicular stores with [3H]noradrenaline and the substantial contribution by leakage of noradrenaline from these stores to DHPG production [18] . In contrast, attainment of steady-state plasma concentrations of [3H]normetadrenaline indicates production of this metabolite from extraneuronal sites, where loading of vesicular stores exerts no influence. Similarly, the much lower specific activities of [3H]DHPG com pared with [3H]normetadrenaline reflect the differ ent sources of these metabolites from neuronal and extraneuronal sites and the much larger contribu tion of circulating noradrenaline to production of normetadrenaline than DHPG.
The potential use of plasma metadrenalines for the clinical examination of extraneuronal catechola mine metabolism is clearly demonstrated in the patients with Norrie disease, where the deficiency of MAO was reflected not only by the complete absence of intraneuronal DHPG production, but also by considerably increased plasma concent rations of metadrenalines. Plasma normetadrenaline was increased about 3-fold more than metadrena line, consistent with findings in rats where pharma cological blockade of MAO increased plasma nor metadrenaline 3-fold more than metadrenaline, a difference due to both increased formation and decreased plasma clearance of normetadrenaline and only decreased clearance of metadrenaline [8] . These findings indicated that little adrenaline or metadrenaline is deaminated in the compartment where metadrenaline is formed, a result explained by differences in rate constants for deamination of adrenaline and noradrenaline. The present findings, showing that most metadrenaline is formed within the adrenals, offer a more likely explanation for the observation that little adrenaline or metadrenaline is deaminated in the compartment where metadrena line is formed [8] .
The marked changes in metabolite profiles in Norrie disease patients illustrate how measurements of plasma metadrenalines in relation to other meta bolites, such as DHPG, may be particularly useful for identification of disorders affecting catechola mine metabolism. Specifically, the pattern of increased plasma concentrations of metadrenalines and decreased concentrations of deaminated meta bolites is characteristic of MAO-deficiency states.
The use of a ratio of these two metabolite groups, while not necessary for identification of the com plete absence of MAO gene expression in the Norrie disease patients studied here, might provide the most sensitive index for detection of partial MAOdeficiency states. Recent identification of a point mutation of the MAO-A gene, associated with bizarre disturbances of behaviour [31, 32] , raises the possibility that other as yet unrecognized deficits in MAO function may exist, associated with more subtle neuropsychological manifestations. Also, recent mapping of the COMT gene to the same site on chromosome 22 [33] where deletions are respon sible for DiGeorge's syndrome [34] , suggests that defective expression of the COMT gene may contri bute to the psychosis associated with this syndrome [35] . Measurements of plasma metadrenalines in conjunction with deaminated metabolites, provide a straightforward approach to detect and quantify neurochemical phenotypes in genetic disorders of catecholamine metabolism and turnover.
